Imunon, Inc.
IMNN
$0.849
$0.01181.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -21.61% | 66.26% | -10.04% | -- | 11.40% |
| Gross Profit | 21.61% | -66.26% | 10.04% | -- | -12.65% |
| SG&A Expenses | -20.76% | -13.26% | -6.25% | -43.95% | -40.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.52% | 27.08% | -8.42% | -11.84% | -15.37% |
| Operating Income | 30.52% | -27.08% | 8.42% | 11.84% | 13.85% |
| Income Before Tax | 34.23% | -39.37% | 13.87% | 11.84% | 58.32% |
| Income Tax Expenses | -- | -- | -- | -- | 18.29% |
| Earnings from Continuing Operations | 17.00% | -39.37% | 13.87% | 11.84% | 63.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.00% | -39.37% | 13.87% | 11.84% | 63.06% |
| EBIT | 30.52% | -27.08% | 8.42% | 11.84% | 13.85% |
| EBITDA | 30.31% | -27.66% | 8.68% | 12.31% | 13.90% |
| EPS Basic | 46.26% | 9.55% | 16.29% | 22.33% | 65.79% |
| Normalized Basic EPS | 57.41% | 9.54% | 11.01% | 22.32% | 16.38% |
| EPS Diluted | 46.26% | 9.55% | 16.29% | 22.33% | 65.79% |
| Normalized Diluted EPS | 57.41% | 9.54% | 11.01% | 22.32% | 16.38% |
| Average Basic Shares Outstanding | 54.45% | 54.05% | 2.89% | 13.50% | 8.00% |
| Average Diluted Shares Outstanding | 54.45% | 54.05% | 2.89% | 13.50% | 8.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |